CoChat

Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice

Open access
Xin, Yang, Diling, Chen, Jian, Yang, Ting, Liu, Guoyan, Hu, Hualun, Liang, Xiaocui, Tang, Guoxiao, Lai, Ou, Shuai, Chaoqun, Zheng, Jun, Zhao, Yizhen, Xie · 2018 · Frontiers in Neurology
Cited by 104

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD), a progressive neurodegenerative disorder, lacks preclinical diagnostic biomarkers and therapeutic drugs. Thus, earlier intervention in AD is a top priority. Studies have shown that the gut microbiota influences central nervous system disorders and that prebiotics can improve the cognition of hosts with AD, but these effects are not well understood. Preliminary research has shown that oligosaccharides from Morinda officinalis (OMO) are a useful prebiotic and cause substantial memory improvements in animal models of AD; however, the mechanism is still unclear. Therefore, this study was conducted to investigate whether OMO are clinically effective in alleviating AD by improving gut microbiota. OMO were administered to APP/PS1 transgenic mice, and potential clinical biomarkers of AD were identified with metabolomics and bioinformatics. Behavioral experiments demonstrated that OMO significantly ameliorated the memory of the AD animal model. Histological changes indicated that OMO ameliorated brain tissue swelling and neuronal apoptosis and downregulated the expression of the intracellular AD marker Aβ1-42. 16S rRNA sequencing analyses indicated that OMO maintained the diversity and stability of the microbial community. The data also indicated that OMO are an efficacious prebiotic in an animal model of AD, regulating the composition and metabolism of the gut microbiota. Serum metabolomic analysis by UHPLC-LTQ Orbitrap mass spectrometry was performed to identify the metabolic changes and potential early biomarkers in APP/PS1 transgenic mice. Multivariate statistical analysis revealed that 14 metabolites were significantly up-regulated and 8 were down-regulated in the model compared with normal mice. This study revealed that key metabolites provide an early indicator of AD incidence. Overall, we have identified a drug and several signaling pathways with therapeutic potential, including proteins associated with cognitive deficits in normal mice and gene mutations that cause AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2018.00412

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 104

Metadata

Authors
Xin, Y., Diling, C., Jian, Y., Ting, L., Guoyan, H., Hualun, L., Xiaocui, T., Guoxiao, L., Ou, S., Chaoqun, Z., Jun, Z., & Yizhen, X.
Venue
Frontiers in Neurology
Published
2018-06-15
Volume
9
Pages
412-412
ISSN
1664-2295 (ISSN-L)
OpenAlex
W2804939759
Cited by
104
References
23
FWCI
7.27
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice. https://app.cochat.ai/papers/10.3389/fneur.2018.00412
The paper
Xin, Y., Diling, C., Jian, Y., Ting, L., Guoyan, H., Hualun, L., Xiaocui, T., Guoxiao, L., Ou, S., Chaoqun, Z., Jun, Z., & Yizhen, X. (2018). Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice. Frontiers in Neurology. https://doi.org/10.3389/fneur.2018.00412

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.